500 West Main Street, 1st Floor
88 articles with Humana, Inc.
Through a new multi-year agreement, Humana will capitalize on infrastructure and capabilities offered by Salesforce Health Cloud to create an integrated health experience for its members
Humana Ranks #1 for Customer Satisfaction for Mail Order in J.D. Power Pharmacy Study for Third Year in a Row
Humana Pharmacy, a division of Humana Inc., has been named the best in Mail Order Pharmacy customer satisfaction in the J.D. Power 2020 U.S. Pharmacy Study.
March of Dimes And The Humana Foundation Partner To Eliminate Health Equity Gap Impacting Moms And Babies Across The U.S.
March of Dimes, the nation's leader in the fight for the health of all moms and babies, and The Humana Foundation, the philanthropic arm of Humana Inc. are working together to address the racial disparities and social determinants of health that contribute to the U.S. maternal and infant health crisis.
Humana to Offer LabCorp At-Home COVID-19 Test Collection and Collaborate with Walmart and Quest Diagnostics to Offer Drive-Thru Testing for Humana Members
Becomes first insurer to provide LabCorp Home Test-Collection Kits to members, and first to offer drive-thru testing for members at Walmart locations
Humana, a national health care company, has announced it is waiving consumer costs for treatment related to COVID-19-covered services.
CAQH announced that Humana Inc., one of the nation's leading health and well-being companies, has joined other national health benefits companies in the effort to improve the accuracy of health care provider directories by participating in CAQH DirectAssure®.
Humana Inc. (NYSE: HUM) today announced it has signed a definitive agreement to acquire privately held Enclara Healthcare (Enclara), one of the nation’s largest hospice pharmacy and benefit management providers, from Consonance Capital Partners and Enclara management.
Award honors specialty pharmacies for their commitment to patients
Humana Inc. announced that its Medicare Advantage plans for 2020 are designed to deliver more ways to care for the whole person through affordable health benefits and wellness programs with added convenience.
J.D. Power Ranks Humana Highest In Mail Order Pharmacy Segment of Customer Satisfaction Study, Two Years in a Row
Humana Pharmacy, a division of Humana Inc., has been named the top U.S. Mail Order Pharmacy in customer satisfaction in the J.D. Power 2019 U.S. Pharmacy Study, two years in a row.
Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, announced today the actions it is taking to assist its members, employees and communities in Florida who may be impacted by Hurricane Dorian.
Aspen RxHealth’s platform connects patients to community pharmacists, optimizing patient interactions
Medication adherence is a big factor in managing chronic diseases and helping patients stay healthy.
Humana and PatientPing Announce Agreement to Improve Care Coordination for Members Across North Carolina
PatientPing, the nation's most comprehensive care coordination platform, announced that it has teamed up with Humana Inc. , one of the nation's leading health and well-being companies, on a new care coordination focus for Humana Medicare Advantage members in North Carolina.
Humana Takes Action in the Fight to Combat America’s Opioid Epidemic
In March, U.S. insurer Cigna Corporation announced it was acquiring pharmacy benefits manager Express Scripts for approximately $52 billion. On Monday, the Department of Justice (DOJ) approved the merger.
Humana Pharmacy, a division of Humana Inc. (NYSE: HUM), has been named the top U.S. Mail Order pharmacy in customer satisfaction in the J.D. Power 2018 U.S. Pharmacy Study.
Humana and Walgreens to Offer Senior-focused Services in Kansas City Area via Primary Care Clinics and In-store Health Navigation Support
Humana Inc. and Walgreens are teaming up to provide easier access to primary care and other services for seniors
One of the hot topics at this year’s BIO International Convention being held in Boston is “patient-centricity."
Loxo Oncology completed the rolling submission of its New Drug Application (INDA) to the U.S. FDA for larotrectinib for adult and pediatric metastatic solid tumors with an NTRK gene fusion. What has caught many investors, analysts and industry observers off-guard is the way the company has downpl...